Mechanism: Circadian BMAL1 phosphorylates Beclin-1, promoting its dissociation from BCL-2 to initiate autophagy during the subjective night. Readout: Readout: Aging reduces BMAL1 activity, decreasing Beclin-1 phosphorylation and autophagy flux, leading to a 25% Lifespan decline; rescue restores flux.
Hypothesis
The core circadian transcription factor BMAL1 directly phosphorylates Beclin-1 at a conserved serine residue, promoting its rhythmic dissociation from BCL-2 and thereby defining daily windows of autophagy initiation. Aging diminishes this BMAL1‑dependent phosphorylation, uncoupling autophagy from circadian timing and contributing to proteostatic decline.
Rationale
- BMAL1 enhances autophagy transcriptionally and suppresses mTORC1, yet no evidence shows it influences the BCL‑2/Beclin-1 checkpoint.[https://pmc.ncbi.nlm.nih.gov/articles/PMC5655224/]
- A Beclin-1 F121A mutation that weakens BCL‑2 binding elevates basal autophagy and extends lifespan, indicating that the timing of this interaction is critical for longevity.[https://pmc.ncbi.nlm.nih.gov/articles/PMC5992097/]
- Autophagy rhythms degrade clock proteins, suggesting a feedback loop where clock‑dependent modifications could reciprocally regulate autophagy machinery.[https://pmc.ncbi.nlm.nih.gov/articles/PMC6082686/]
We propose that BMAL1, through its kinase‑associated activity or by recruiting a circadian‑regulated kinase (e.g., CK1δ/ε), phosphorylates Beclin-1 at Ser‑90 (or an equivalent site). This modification reduces Beclin-1’s affinity for BCL-2, allowing phagophore assembly during the subjective night when cellular energy status favors catabolism. Conversely, during the subjective day, low phosphorylation maintains the inhibitory BCL‑2/Beclin-1 complex, preventing premature autophagy that could interfere with anabolic processes.
Predictions
- Rhythmic phosphorylation: Immunoprecipitation followed by phospho‑specific Western blot will show circadian oscillation of Beclin-1 phosphorylation at the predicted site, peaking in the early subjective night in wild‑type mouse liver and fibroblasts.
- BMAL1 dependence: Bmal1 knockdown or CRISPR‑mediated deletion will abolish the phosphorylation rhythm without altering total Beclin-1 levels, leading to a constitutively high BCL‑2/Beclin-1 interaction.
- Functional consequence: Expressing a phospho‑deficient Beclin-1 mutant (S90A) will flatten autophagy flux across the circadian cycle, whereas a phospho‑mimetic mutant (S90D) will restore nocturnal autophagy peaks even in Bmal1‑deficient cells.
- In vivo aging test: Aged mice will exhibit reduced amplitude of Beclin-1 phosphorylation and a shifted phase relative to young controls; rescuing BMAL1 expression in the liver of aged mice will reinstate the phosphorylation rhythm and improve autophagic flux, as measured by LC3‑II turnover and p62 degradation.
- Lifespan impact: Chronic expression of phospho‑mimetic Beclin-1 in Bmal1 heterozygous mice will mitigate age‑related cardiac and hepatic decline, extending median lifespan compared with controls.
Experimental Approach
- Cell models: Primary hepatocytes and NIH‑3T3 fibroblasts transfected with circadian reporters (Bmal1‑Luc) to synchronize clocks.
- Phospho‑mapping: Use mass spectrometry to identify BMAL1‑dependent phospho‑sites on Beclin-1; validate with custom antibodies.
- Interaction assays: Perform GST‑pull‑down or co‑IP to quantify BCL‑2/Beclin-1 binding at multiple circadian times under wild‑type, Bmal1 KO, and rescue conditions.
- Autophagy read‑outs: Monitor LC3‑II accumulation with bafilomycin A1, mCherry‑GFP‑LC3 flux, and p62 degradation via flow cytometry and immunoblotting.
- In vivo validation: Generate liver‑specific Bmal1 knock‑in mice expressing phospho‑deficient or phospho‑mimetic Beclin-1; assess circadian autophagy markers via zeitgeber‑time‑sequenced tissue collection.
- Aging cohorts: Compare young (3 mo) and aged (24 mo) mice for phosphorylation rhythm, autophagic activity, and functional outcomes (echocardiography, fibrosis histology).
Falsifiability
If BMAL1 manipulation does not alter the circadian phosphorylation state of Beclin-1, or if altering Beclin-1 phosphorylation fails to rescue autophagy rhythms in Bmal1‑deficient cells, the hypothesis would be refuted. Conversely, demonstration of a BMAL1‑dependent, rhythmic phospho‑switch that directly gates the BCL‑2/Beclin-1 interaction would substantiate the model and position the circadian clock as a direct checkpoint regulator of autophagy initiation.
Comments
Sign in to comment.